Suchergebnisse - "McCluskey, Peter J"

PubPharm (6)

1

Re : Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424)

enthalten in: Ophthalmology | 2019

von Symes, R. | Zagora, S. | Younan, C. | +1

CommentOn: Ophthalmology. 2019 Mar;126(3):415-424. - PMID 30336181

2

Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy : a tertiary referral cohort study

enthalten in: Ophthalmology | 2015

von Yates, W. | Vajdic, C. | Na, R. | +2

CommentIn: Ophthalmology. 2015 Feb;122(2):219-21. - PMID 25618424

3

Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study

enthalten in: Ophthalmology | 2015

von Yates, W. | Vajdic, C. | Na, R. | +2

4

Acetazolamide in retinoschisis : a prospective study

enthalten in: Ophthalmology | 2014

von Gurbaxani, A. | Wei, M. | Succar, T. | +3

5

Acetazolamide in Retinoschisis: A Prospective Study

enthalten in: Ophthalmology | 2014

von Gurbaxani, A. | Wei, M. | Succar, T. | +3

6

Posterior Scleritis: Clinical Features, Systemic Associations, and Outcome in a Large Series of Patients - Posterior scleritis is an under-recognized disease frequently accompanied by visual loss, anterior scleritis, and associated systemic disease. Statistical analysis failed to reveal any association between the mode of presentation, age, or sex of the patient and associated systemic disorder. It is therefore necessary to regard every patient with posterior scleritis as having a potentially blinding disease

enthalten in: Ophthalmology | 1999

von McCluskey, P. | Watson, P. | Lighmian, S. | +3

1
[1]